🔎 Trials Near Me

Dachaigh › Galar Depressive Mòr › Florida

Sgrùdaidhean clionaigeach Galar Depressive Mòr ann an Florida

Tha 32 sgrùdaidhean airson Galar Depressive Mòr a’ lorg phàirtichean aig làraichean ann an Florida.

Bailtean ann an Florida

Teacsa sgrùdaidh oifigeil (Beurla)

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  • JEM Research Institute, Atlantis
  • Bradenton Research Center, Inc., Bradenton
  • Key Clinical Research, Bradenton
  • agus 6 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07775300

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

  • UHC Research, Doral
  • Reliable Clinical Research, Hialeah
  • Pharmax Research Clinic Inc, Miami
  • agus 3 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07573176

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

  • Clinical Research of Brandon, Brandon
  • AGA Clinical Trials, Hialeah
  • Reliable Clinical Research, Hialeah
  • agus 9 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

  • Clinical Neuroscience Solutions Inc. - Jacksonville, Jacksonville
  • K2 Medical Research - Maitland, Maitland
  • Central Miami Medical Institute Llc., Miami
  • agus 3 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07621237

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

  • Premier Clinical Research Institute, Miami
  • Miami Jewish Health System, Miami
  • Interventional Psychiatry of Tampa Bay, Tampa
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05850689

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

  • CNS Healthcare, Jacksonville
  • Accel Research Sites - Maitland, Maitland
  • Aqualane Clinical Research, Naples
  • agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06793397

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

  • Vanda Investigational Site, Fort Myers
  • Vanda Investigational Site, Miami
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06830044

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

  • Neurocrine Clinical Site, Bonita Springs
  • Neurocrine Clinical Site, Hialeah
  • Neurocrine Clinical Site, Miami
  • agus 3 a bharrachd
A’ fastadhÌre 4
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT07105111

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

  • Seaport Investigator Site, Jacksonville
  • Seaport Investigator Site, Lauderhill
  • Seaport Investigator Site, Orlando
  • agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07065240

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

  • New Access Research and Medical Services, Inc., Fort Myers
  • The Medici Medical Research, Hollywood
  • Clinical Neuroscience Solutions, Inc., Orlando
  • agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07284667

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

  • Gulfcoast Clinical Research Center, Fort Myers
  • Sarkis Clinical Trials, Gainesville
  • Equipath Health and Research Tampa Bay, Llc, Riverview
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07076407

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

  • Draig Clinical Site, Hialeah
  • Draig Clinical Site, Orlando
  • Draig Clinical Site, Orlando
  • agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07610473

Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression

  • Florida State University, Tallahassee
A’ fastadh
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 31 Lùna 2026 · NCT06132581

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

  • USF Health, Tampa
A’ fastadh
Aoisean 22 gu 70 · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT06423430

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

  • Draig Clinical Site, Miami
  • Draig Clinical Site, New Port Richey
  • Draig Clinical Site, Orlando
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07300969

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Hollywood
  • Neurocrine Clinical Site, Tampa
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT06911112

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

  • Clinical Neuroscience Solutions, LLC (Jacksonville), Jacksonville
  • K2 Medical Research (Maitland), Maitland
  • Clinical Neuroscience Solutions, LLC (Orlando), Orlando
  • agus 2 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT07592689

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Maitland
  • Neurocrine Clinical Site, Miami
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT06963021

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  • Encore Medical Research, Hollywood
  • K2 Medical Research - Maitland, Maitland
  • Life Medical Research Group Corp, Miami Gardens
  • agus 5 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT07412756

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  • CNS Clinical Research Group, Coral Springs
  • Clinical Neuroscience Solutions, Inc., Jacksonville
  • Accel Research Sites Lakeland, Lakeland
  • agus 4 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06775379

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

  • Clinical Neuroscience Solutions, Inc., Jacksonville
  • D&H Pompano Research Center, LLC, Margate
  • Premier Clinical Research Institute, Inc., Miami
  • agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06547489

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

  • Clinical Neuroscience Solutions, Inc, Jacksonville
  • Premier Clinical Research Institute Inc, Miami
  • Aqualane Clinical Research, Naples
  • agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07115329

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Miami Gardens
  • Neurocrine Clinical Site, Orlando
  • Neurocrine Clinical Site, Palm Bay
  • agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT07196501

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Hollywood
  • Neurocrine Clinical Site, Maitland
  • Neurocrine Clinical Site, Maitland
  • agus 5 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT06966401

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

  • Clinical Research Site, Jacksonville
  • Clinical Research Site, Miami
  • Clinical Research Site, Miami
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT07484217

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

  • CenExel Hollywood FL /ID# 278200, Hollywood
  • Cns Healthcare - Jacksonville /ID# 277658, Jacksonville
  • GMI Florida - Central Miami Medical Institute /ID# 278218, Miami
  • agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 15 Ògmh 2026 · NCT07276997

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  • CenExel, Hollywood
  • Bioresearch Partner, Miami
  • University of South Florida, Psychiatry and Behavioral Neurosciences, Tampa
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 11 Cèit 2026 · NCT06524830

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

  • Autobahn Site #108, Brandon
  • Autobahn Site #110, Hialeah
  • Autobahn Site #101, Jacksonville
  • agus 3 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 20 Faoi 2026 · NCT06633016

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Hollywood
  • Neurocrine Clinical Site, Maitland
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Dàmh 2025 · NCT06786624

Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics

  • AdventHealth Neuroscience Institute, Orlando
A’ fastadh
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 22 Dàmh 2025 · NCT05877885

Study of ALTO-300 in MDD

  • Site 159, Clermont
  • Site 225, Miami Gardens
  • Site 190, Miami Lakes
  • agus 3 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 24 Iuch 2025 · NCT05922878

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

  • Clinical Research Site, Brandon
  • Clinical Research Site, Doral
  • Clinical Research Site, Hialeah
  • agus 5 a bharrachd
A’ fastadhÌre 4
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 23 Faoi 2025 · NCT06223880

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.